Literature DB >> 29328003

Characterizing the type and location of intracranial abnormalities in mild traumatic brain injury.

Harri Isokuortti1, Grant L Iverson2,3,4,5, Noah D Silverberg2,6,5,7, Anneli Kataja8, Antti Brander8, Juha Öhman9, Teemu M Luoto9.   

Abstract

OBJECTIVEThe incidence of intracranial abnormalities after mild traumatic brain injury (TBI) varies widely across studies. This study describes the characteristics of intracranial abnormalities (acute/preexisting) in a large representative sample of head-injured patients who underwent CT imaging in an emergency department.METHODSCT scans were systematically analyzed/coded in the TBI Common Data Elements framework. Logistic regression modeling was used to quantify risk factors for traumatic intracranial abnormalities in patients with mild TBIs. This cohort included all patients who were treated at the emergency department of the Tampere University Hospital (between 2010 and 2012) and who had undergone head CT imaging after suffering a suspected TBI (n = 3023), including 2766 with mild TBI and a reference group with moderate to severe TBI.RESULTSThe most common traumatic lesions seen on CT scans obtained in patients with mild TBIs and those with moderate to severe TBIs were subdural hematomas, subarachnoid hemorrhages, and contusions. Every sixth patient (16.1%) with mild TBI had an intracranial lesion compared with 5 of 6 patients (85.6%) in the group with moderate to severe TBI. The distribution of different types of acute traumatic lesions was similar among mild and moderate/severe TBI groups. Preexisting brain lesions were a more common CT finding among patients with mild TBIs than those with moderate to severe TBIs. Having a past traumatic lesion was associated with increased risk for an acute traumatic lesion but neurodegenerative and ischemic lesions were not. A lower Glasgow Coma Scale score, male sex, older age, falls, and chronic alcohol abuse were associated with higher risk of acute intracranial lesion in patients with mild TBI.CONCLUSIONSThese findings underscore the heterogeneity of neuropathology associated with the mild TBI classification. Preexisting brain lesions are common in patients with mild TBI, and the incidence of preexisting lesions increases with age. Acute traumatic lesions are fairly common in patients with mild TBI; every sixth patient had a positive CT scan. Older adults (especially men) who fall represent a susceptible group for acute CT-positive TBI.

Entities:  

Keywords:  CDE = Common Data Element; DAI = diffuse axonal injury; ED = emergency department; GCS = Glasgow Coma Scale; LOC = loss of consciousness; MTBI = mild traumatic brain injury; PTA = posttraumatic amnesia; WHO = World Health Organization; common data elements; computed tomography; head injury; neurodegenerative diseases; trauma; traumatic brain injury

Mesh:

Year:  2018        PMID: 29328003     DOI: 10.3171/2017.7.JNS17615

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

Review 1.  Volumetric MRI Findings in Mild Traumatic Brain Injury (mTBI) and Neuropsychological Outcome.

Authors:  Erin D Bigler
Journal:  Neuropsychol Rev       Date:  2021-03-03       Impact factor: 7.444

Review 2.  S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy.

Authors:  Michael Amoo; Jack Henry; Philip J O'Halloran; Paul Brennan; Mohammed Ben Husien; Matthew Campbell; John Caird; Mohsen Javadpour; Gerard F Curley
Journal:  Neurosurg Rev       Date:  2021-10-28       Impact factor: 3.042

Review 3.  Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Prediction of Computed Tomography Findings in Traumatic Brain Injury; a Meta-Analysis.

Authors:  Fatemeh Ramezani; Amir Bahrami-Amiri; Asrin Babahajian; Kavous Shahsavari Nia; Mahmoud Yousefifard
Journal:  Emerg (Tehran)       Date:  2018-12-15

4.  Patients with Mild Traumatic Brain Injury Recruited from Both Hospital and Primary Care Settings: A Controlled Longitudinal Magnetic Resonance Imaging Study.

Authors:  Cathrine Elisabeth Einarsen; Kent Gøran Moen; Asta Kristine Håberg; Live Eikenes; Kjell Arne Kvistad; Jian Xu; Hans Kristian Moe; Marie Hexeberg Tollefsen; Anne Vik; Toril Skandsen
Journal:  J Neurotrauma       Date:  2019-07-31       Impact factor: 5.269

5.  GCS 15: when mild TBI isn't so mild.

Authors:  Latha Ganti; Tej Stead; Yasamin Daneshvar; Aakash N Bodhit; Christa Pulvino; Sarah W Ayala; Keith R Peters
Journal:  Neurol Res Pract       Date:  2019-02-28

6.  Return to work after mild traumatic brain injury: association with positive CT and MRI findings.

Authors:  Antti Huovinen; Ivan Marinkovic; Harri Isokuortti; Antti Korvenoja; Kaisa Mäki; Taina Nybo; Rahul Raj; Susanna Melkas
Journal:  Acta Neurochir (Wien)       Date:  2022-05-31       Impact factor: 2.816

7.  EEG hyperscanning in motor rehabilitation: a position paper.

Authors:  Matthew R Short; Julio C Hernandez-Pavon; Alyssa Jones; Jose L Pons
Journal:  J Neuroeng Rehabil       Date:  2021-06-10       Impact factor: 4.262

8.  Functional outcome, in-hospital healthcare consumption and in-hospital costs for hospitalised traumatic brain injury patients: a Dutch prospective multicentre study.

Authors:  Jeroen T J M van Dijck; Cassidy Q B Mostert; Alexander P A Greeven; Erwin J O Kompanje; Wilco C Peul; Godard C W de Ruiter; Suzanne Polinder
Journal:  Acta Neurochir (Wien)       Date:  2020-05-14       Impact factor: 2.216

9.  Effect of mild blast-induced TBI on dendritic architecture of the cortex and hippocampus in the mouse.

Authors:  Whitney A Ratliff; Ronald F Mervis; Bruce A Citron; Brian Schwartz; Vardit Rubovitch; Shaul Schreiber; Chaim G Pick
Journal:  Sci Rep       Date:  2020-02-10       Impact factor: 4.379

10.  Craniotomies following acute traumatic brain injury in Finland-a national study between 1997 and 2018.

Authors:  Nea Nevalainen; Teemu M Luoto; Grant L Iverson; Ville M Mattila; Tuomas T Huttunen
Journal:  Acta Neurochir (Wien)       Date:  2022-02-04       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.